Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NEUP

Neuphoria Therapeutics Inc.

CIK 0001191070 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$3.91
↓ 0.04 (-1.01%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$21.13M
P/E Ratio
-1.21
EPS
-0.23
Dividend Yield
Not covered
52W Position
4%
Beta
1.17

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.72
P/S
Not covered
EV/Revenue
Not covered
ROE
-59.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$3.19$21.40

Latest Financials

2025-06-30 FY
Revenue
$15.65M
Net Income
-$369.63K
Total Assets
$28.59M
Free Cash Flow
–

Recent news